Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
about
Review of tenofovir-emtricitabine.Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation.Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results.Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study.
P2860
Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@ast
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@en
type
label
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@ast
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@en
prefLabel
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@ast
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@en
P2860
P356
P1476
Tenofovir disoproxil fumarate- ...... once-daily dual NRTI backbone.
@en
P2093
Jose Ramón Arribas López
Rosa María Muñoz de Benito
P2860
P304
P356
10.1586/14787210.4.4.523
P577
2006-08-01T00:00:00Z